Money

Could China’s COVID vaccine save the world?

Most scientists are of the view that coronavirus originated from China, after all Wuhan was ground zero for the pandemic which began early last year.

Since then, millions have died and many more have been infected. Our way of life has been turned upside down.

Now the World Health organisation has granted emergency approval for China’s COVID vaccine – which is made by Chinese state-owned company Sinopharm.

It is the first vaccine developed by a non-Western country to get WHO backing.Β And it’s big news, especially for developing nations.

The vaccine has already been given to millions of people in China and elsewhere.Β 

Already, health regulators in various countries – especially poorer ones in Africa, Latin America and Asia – have approved Chinese jabs for emergency use.

The effectiveness of the various Chinese vaccines has long been uncertain.

WHO says the addition of the vaccine had “the potential to rapidly accelerate Covid-19 vaccine access for countries seeking to protect health workers and populations at risk”.

It is recommending that the vaccine be administered in two doses, especially to those aged 18 and over.

https://twitter.com/WHO/status/1390704054267961346?s=20

Does it even matter?

The green light from the global health body is a guideline for national regulators that a vaccine is safe and effective. 

WHO director-general Tedros Adhanom Ghebreyesus said it would give countries “confidence to expedite their own regulatory approval”.

In addition to China, countries already using the vaccine include the UAE, Pakistan and Hungary. 

The decision on Friday to approve the vaccine for emergency use was made by the WHO’s technical advisory group, which reviewed the latest clinical data and manufacturing practices. 

It said the vaccine’s efficacy for symptomatic and hospitalised cases of Covid-19 was estimated to be 79%.

Up next
Media accountability and Trump’s political fallout put journalism under scrutiny

Media credibility and changing audience interests are putting journalism under the spotlight.

Read the story →
Ticker Today takes a daily view of the world of news, politics and business.With Ahron YoungWhisky & Suits explores law, property finance and business over fine whisky.With Imran Khan and Chris ChristofiThe Founders Method explores practical lessons and systems for entrepreneursWith Jonathan Byrt and Jesse LeeworthyThe Connector explores property and urban growth across Australia and the UK.With Belinda CoateThe Property Playbook delivers research-led insights for property investors.With Tim Graham and Terry RyderState of Hospitality explores the challenges facing Australia's hospitality.With Jeremy KoadlowBuying Power helps young professionals enter property and build lasting wealth.With Victor and Reshmi KumarThe Airport Economist explores global trade, business and economic outlooks.With Tim HarcourtMedia Movers explores the trends shaping Australia's media and global news.With James ManningBroker Business explores strategies to build, grow and sustain a business.With Rex AfrasiabiMoney Matters explores practical financial strategies to build lasting wealth.With Dr Steven EnticottBeyond Education explores the ideas and technology shaping future learning.With Greg CampitelliTicker Air explores the latest aviation news, travel trends and developments.With Ahron YoungEarly Years Dialogue explores the issues shaping Australia's early learning.With Paul MondoMarkets and Machines explores AI, regulation and trends shaping the markets.With Chris BergSocial Intelligence explores how social media and AI transform our daily lives.With Dr Karen SutherlandThe AI Edge explores how artificial intelligence reshapes the world economy.With Brad Gastwirth

More from Ticker

Watch

More in Money

View all →